Clinical Trial Update: A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating gilteritinib in combination with either ivosidenib or enasidenib in patients with acute myeloid leukemia is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Enasidenib (enasidenib)
• Gilteritinib (gilteritinib)
• Ivosidenib (ivosidenib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Acute Myeloid Leukemia (AML) | Phase 1 | Status: RECRUITING